Soluble ICAM-1 and E-selectin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndome Yoram Abramov, M.D., Joseph.

Slides:

Advertisements

Similar presentations

Early-stage endometriosis: adhesion and growth of human menstrual endometrium in nude mice Michelle Nisolle, M.D., Ph.D., Françoise Casanas-Roux, B.S.,

Advertisements

Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles Ryan G. Steward,

Maria Jose G. Teruel, Ph. D. , Luis F. Carbonell, Ph. D

Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome

Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated.

Andrew J. Krentz, M.D., Elizabeth Barrett-Connor, M.D.

Human chorionic gonadotropin administration does not increase plasma androgen levels in patients undergoing controlled ovarian hyperstimulation Renato.

Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated.

Local injury to the endometrium in controlled ovarian hyperstimulation cycles improves implantation rates Liang Zhou, M.D., Rong Li, M.D., Ph.D., Rong.

Anil K Dubey, Ph. D. , Jose R Cruz, M. D. , Beth Hartog, M. D

Postparacentesis bilateral massive vulvar edema in a patient with severe ovarian hyperstimulation syndrome Dimitrios Vavilis, M.D., Stergios Tzitzimikas,

Value of the serum estradiol level for preventing ovarian hyperstimulation syndrome: a retrospective case control study Arianna D'Angelo, M.D., Rachel.

Kalliopi Kotsa, M. D. , Ph. D. , Maria P. Yavropoulou, M. D

Regulation of vascular endothelial growth factor-A and its soluble receptor sFlt-1 by luteinizing hormone in vivo: implication for ovarian follicle angiogenesis

Joanne F. Dorgan, Ph. D. , Cynthia S. Spittle, Ph. D. , Brian L

Patient-tailored ovarian stimulation for in vitro fertilization

Raoul Orvieto, M. D. , M. Sc. , Eduard Hod, M. D

Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome

Seasonal variations and age-related changes in human sperm count, motility, motion parameters, morphology, and white blood cell concentration Grace M.

Serum concentrations of interleukin-2R (IL-2R), IL-6, IL-8, and tumor necrosis factor alpha in patients with ectopic pregnancy David Soriano, M.D., Danielle.

Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women Carlos Iglesias, M.D., Manish Banker, M.D.,

Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study Nicole Hope, M.B., B.S., Hon., Luk.

Effect of the initiation of progesterone supplementation in in vitro fertilization–embryo transfer outcomes: a prospective randomized controlled trial

Day 4 Estradiol Levels Predict Pregnancy Success in Women Undergoing Controlled Ovarian Hyperstimulation for IVF John Y Phelps, M.D., Adam S Levine,

Three-dimensional ultrasonographic ovarian measurements and in vitro fertilization outcome are related to age Sanja Kupesic, M.D., Ph.D., Asim Kurjak,

The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1β, interleukin-6, and vascular endothelial.

Predicted value of renin activity in a woman who had severe ovarian hyperstimulation syndrome with internal jugular vein thrombosis Fung-Wei Chang, M.D.,

The measurements of RAGE, VEGF, and AGEs in the plasma and follicular fluid of reproductive women: the influence of aging Eriko Y. Fujii, M.D., Ph.D.,

A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data

Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian.

Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 μg) and ethinyl estradiol (15 μg) on ovarian activity Helen Sullivan,

Toxic Effects Associated With Consumption of Zinc

Significant elevation of plasma matrix metalloproteinase-9 level and its ratio to matrix metalloproteinase-2 in patients with pelvic inflammatory disease

Vivian Barak, Ph. D. , Uriel Elchalal, M. D. , Michal Edelstein, M. D

Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis Laura P. Smith, M.D.,

Mohamed Fawzy, M. D. , Mohamed Y. AbdelRahman, M. D. , Mohamed H

Reduction of ovarian torsion 1 week after embryo transfer in a patient with bilateral hyperstimulated ovaries Anil B Pinto, M.D., Valerie S Ratts, M.D.,

Changes in cytokine levels of patients with ovarian endometriosis after treatment with gonadotropin-releasing hormone analogue, ultrasound-guided drainage,

Comparison of two methods for the measurement of sperm concentration

Relationship between serum leptin concentrations and bone mineral density as well as biochemical markers of bone turnover in women with postmenopausal.

Endocrine gland–derived vascular endothelial growth factor concentrations in follicular fluid and serum may predict ovarian hyperstimulation syndrome.

Luteal support with intravaginal progesterone increases clinical pregnancy rates in women with polycystic ovary syndrome using letrozole for ovulation.

Concentration of vascular endothelial growth factor released by cultured human luteinized granulosa cells is higher in women with polycystic ovaries than.

Pyridostigmine cotreatment for controlled ovarian hyperstimulation in low responders undergoing in vitro fertilization–embryo transfer Chung-Hoon Kim,

Regulation of assisted reproductive technologies in the United States

Decreased levels of interleukin-18 in peritoneal fluid but not in serum of patients with endometriosis Xinmei Zhang, M.D., Jun Lin, M.D., Yuli Qian,

A case of ovarian hyperstimulation syndrome associated with the methylenetetrahydrofolate reductase mutation gene Filippo Ferrara, M.D., Francesco Meli,

Cabergoline and Ganirelix Therapy for Early Moderate to Severe Ovarian Hyperstimulation Syndrome (OHSS) Results in Faster Recovery than in Early Untreated.

Effect of angiotensin-converting enzyme inhibitor on renal function in ovarian hyperstimulation syndrome in the rabbit Maria Jose G Teruel, Ph.D., Luis.

Anuja Dokras, M. D. , Ph. D. , Antonia Habana, M. D. , Juan Giraldo, M

Effectiveness of cetrorelix for the prevention of premature luteinizing hormone surge during controlled ovarian stimulation using letrozole and gonadotropins:

Impact of leuprolide acetate on luteal phase function in women undergoing controlled ovarian hyperstimulation and intrauterine insemination Deirdre A.

Withholding gonadotropins (“coasting”) to minimize the risk of ovarian hyperstimulation during superovulation and in vitro fertilization–embryo transfer.

Kurt T Barnhart, M. D. , M. S. C. E. , Paolo Rinaudo, M. D. , Ph. D

Cost-effectiveness comparison between pituitary down-regulation with a gonadotropin- releasing hormone agonist short regimen on alternate days and an antagonist.

Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr Murat Arslan, M.D.,

Ariel Weissman, M. D. , Amihai Barash, M. D. , Moshe Manor, M. D

Altered osmotic thresholds for arginine vasopressin secretion and thirst during superovulation and in the ovarian hyperstimulation syndrome (OHSS): relevance.

Lower levels of inhibin A and pro-αC during the luteal phase after triggering oocyte maturation with a gonadotropin-releasing hormone agonist versus human.

Serum levels of soluble vascular cell adhesion molecule-1 are decreased in women receiving oral contraceptives compared with normally menstruating women:

Saad Elzanaty, M.D., Ph.D., Johan Malm, M.D., Ph.D.

Effectiveness of human menopausal gonadotropin versus recombinant follicle- stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive.

Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles David.

Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles

Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome

Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome Basak Yildirim, M.D., Nuran Sabir,

Thyroid function after controlled ovarian hyperstimulation in women with and without the hyperstimulation syndrome Kris Poppe, M.D., Ph.D., David Unuane,

Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles2

Stephen J Winters, M. D. , Evelyn Talbott, David S Guzick, Ph. D. , M

Superoxide dismutase activity in human follicular fluid after controlled ovarian hyperstimulation in women undergoing in vitro fertilization Luca Sabatini,

Presentation transcript:

Soluble ICAM-1 and E-selectin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndome Yoram Abramov, M.D., Joseph G Schenker, M.D., Aby Lewin, M.D., Irit Kafka, M.D., Haim Jaffe, M.D., Vivian Barak, Ph.D. Fertility and Sterility Volume 76, Issue 1, Pages 51-57 (July 2001) DOI: 10.1016/S0015-0282(01)01820-9

Figure 1 Leukocyte count (WBC) and hematocrit (HCT) in patients with the ovarian hyperstimulation syndrome. Values are means ± SE of three serial blood samples. All differences between the three samples were statistically significant (P<.05). Abramov. Soluble ICAM-1 and E-Selectin in OHSS. Fertil Steril 2001. Fertility and Sterility 2001 76, 51-57DOI: (10.1016/S0015-0282(01)01820-9)

Figure 2 Serum concentrations of soluble (s) intracellular adhesion molecule (ICAM)-1 and soluble E-selectin in patients with the ovarian hyperstimulation syndrome during the acute phase (dark bars) and in controls (white bars). Values are means ± SE. ∗P<.05 between patients and controls. Abramov. Soluble ICAM-1 and E-Selectin in OHSS. Fertil Steril 2001. Fertility and Sterility 2001 76, 51-57DOI: (10.1016/S0015-0282(01)01820-9)

Figure 3 Kinetics of serum soluble (s) intercellular adhesion molecule (ICAM)-1 and soluble E-selectin in patients with the ovarian hyperstimulation syndrome. Values are means ± SE. All differences between samples obtained during the acute phase and those obtained during convalescence or resolution were statistically significant (P<.05). Abramov. Soluble ICAM-1 and E-Selectin in OHSS. Fertil Steril 2001. Fertility and Sterility 2001 76, 51-57DOI: (10.1016/S0015-0282(01)01820-9)